China Next Gen Sequencing.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

China Next Gen Sequencing.Pdf SCIENCE CHINA Life Sciences January 2010 Vol.53 No.1: 44–57 Celebrating Scientia Sinica doi: 10.1007/s11427-010-0023-6 (SCIENCE CHINA)’S the 60th Anniverasry · REVIEW · The next-generation sequencing technology: A technology review and future perspective ZHOU XiaoGuang1†*, REN LuFeng1†, LI YunTao2, ZHANG Meng1, YU YuDe2 & YU Jun1* 1 Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, China; 2 Institute of Semiconductor, Chinese Academy of Sciences, Beijing 100083, China Received December 8, 2009; accepted December 16, 2009 As one of the most powerful tools in biomedical research, DNA sequencing not only has been improving its productivity in an exponential growth rate but also been evolving into a new layout of technological territories toward engineering and physical disciplines over the past three decades. In this technical review, we look into technical characteristics of the next-gen sequenc- ers and provide prospective insights into their future development and applications. We envisage that some of the emerging platforms are capable of supporting the $1000 genome and $100 genome goals if given a few years for technical maturation. We also suggest that scientists from China should play an active role in this campaign that will have profound impact on both scientific research and societal healthcare systems. genomics, DNA sequencing, next generation sequencing technologies, sequencer Citation: Zhou X G, Ren L F, Li Y T, et al. The next-generation sequencing technology: A technology review and future perspective. Sci China Life Sci, 2010, 53: 44–57, doi: 10.1007/s11427-010-0023-6 1 Introduction propel creation and development of other branches of ge- nomic studies such as comparative genomics and bioinfor- matics as well as closely related fields such as systems bi- DNA sequencing technology has played an essential role in ology and synthetic biology. In a way, technological ad- the advancement of molecular biology ever since its inven- vancement in DNA sequencing has transformed the study of tion [1]. From early manual sequencing operation developed fundamental element of life – from individual, localized by Frederick Sanger, first-generation automated sequencer genes or fragment of genes to whole genomes, which in turn driven by Sanger chemistry, to present next-gen sequencing demands more competent sequencing technology. The syn- platforms, we have witnessed tremendous changes in this ergetic relationship between sequencing and its applications field [2]. Some even liken this change in genomic sequencing ensures that the trend will continue in foreseeable future and to the evolution of semiconductor technology [3]. This is not even accelerate due to the promise of and drive for person- totally unfounded – the speed of sequencing has improved alized medicine in disease diagnosis and treatment. Here, exponentially every few years over the last few decades, we provide a review of sequencing technology evolution, similar to what semiconductor industry has experienced summary of generational advancements with their merits under the Moore’s law [4]. This rapid transformation is and drawbacks, and prediction of possible direction of the captured in Figure 1 and has fundamentally changed the field. For ease of discussion, we categorize the progress of way we can examine the blue-print of all life and helps to sequencing technology into three generations with sub- † Contributed equally to this work *Corresponding author (email:[email protected]; [email protected]) © Science China Press and Springer-Verlag Berlin Heidelberg 2010 life.scichina.com www.springerlink.com Zhou XiaoGuang, et al. Sci China Life Sci January (2010) Vol.53 No.1 45 time, to study in depth the genetic code of life. The original method was primarily a manual endeavor and hard to automate. For one, it utilized isotopic radioac- tive labeling of primer for DNA ladder imaging, making the sequencing process non-user friendly. The requirement of four separate chain-termination reactions with dideoxynu- cleotides (ddNTPs) and subsequent slab-gel based separa- tion of chain-terminated products on four individual elec- trophoretic lanes are both time- and reagent-consuming. All these severely limited the overall throughput of sequencing- hence, the desire to develop non-radioactive based 1st gen- eration sequencing technology. 2.1.1 G1.1 Figure 1 Sequencing technology timeline The initial version of 1st generation sequencer first appeared in mid 80s and developed in Leroy Hood’s laboratory at Cal generations as illustrated in Table 1. The designation of each Tech [6]. It made possible through modifications to the state of advancement is somewhat arbitrary but nevertheless Sanger’s method. The key improvement includes the use of it captures the key delineation of technological advances of color fluorescent dyes to replace radioactive labeling - four each period. dideoxynucleotide terminators are tagged with differently colored fluorophores. Furthermore, the tag is attached to the terminator molecule (ddNTPs) instead of the primer as in 2 A review of the technology and its recent de- the case of original Sanger’s method. The color-coded velopments scheme made it possible to perform all four chain-termina- tion reactions in one tube. Polyacrylamide gel analysis of 2.1 1st generation technology – fluorescently labeled ladder fragments can be performed through computerized sanger method fluorescence detection system. This greatly enhanced the overall sequencing speed and reduced manual intervention Before the appearance of first automated DNA sequencing required by operator during sequencing run. platform, widely accepted DNA sequencing method of In the following year, ABI introduced its first semi- choice had been the Sanger’s chain-termination method automated DNA sequencing platform, e.g. ABI 370 Se- developed in the mid 1970s, for which Sanger was awarded quencer, based on the technology from Leroy Hood’s lab [7]. the Nobel Chemistry Prize in 1980 [5]. His invention In the subsequent two decades, we had experienced a rapid opened a realm of possibility for researchers, for the first change and improvement of its performance. But the under- Table 1 Roadmap of sequencing technologya) Generation 1st-G 2nd-G 3rd-G Version 1.1 1.2 2.1 2.2 2.3 3.1 3.2 ABI/GenoME Sanger ABI MS SBS Illumina Complete Ge- SBL ABI/Polonator G.007 nomics SBP Roche FD Helicos Platform SM-SBS Pacific Biosciences/ ? FE VisiGen SM-SBL SM-SBP Pore PoC Nano Nife PoC Graphene PoC a) SBS, sequence-by-synthesis; SBL, sequence-by-ligation; SBP: sequence-by- pyrosequencing; SM: single molecule, FD: fixed DNA; FE: fixed en- zyme, PoC: proof-of-concept; ?: expected technology 46 Zhou XiaoGuang, et al. Sci China Life Sci January (2010) Vol.53 No.1 pinning working principle has not changed until very re- tions of sequencing platform. The reliability, raw accuracy, cently. scalability of the tried-and-true method will continue to play an important role, especially in sequencing PCR products 2.2.2 G1.2 and clone-ends of plasmids and bacterial artificial chromo- Toward the end of last century, the second version of the somes as well as genotyping for STR markers. 1st-generation technology appeared. With it, we see further enhancement in the speed and quality of DNA sequencing. 2.2 2nd Generation technologies – cyclic array sequenc- This was mainly achieved through improvements in two ing by Synthesis areas. First, slab-gel based separation was replaced by cap- illary-electrophoresis, and second, number of concurrent The so-called next generation sequencing methods encom- samples that can be analyzed was increased through higher pass a myriad of approaches based on different technology. parallelism. The use of capillary instead slab-gel eliminated Although utilized quite diverse techniques and biochemistry sample loading, reduced the reagent consumption and sped in each step from template library preparation, fragment up analysis. Further, the compact form of capillary device amplification, to sequencing, they all adopted a massive makes it easier to parallelize multiple sequencing runs, re- matrix configuration popularized by microarray analysis – sulting in higher instrument throughput; 96 samples on ABI DNA samples on the array are simultaneously analyzed in 3730 platform and 384 samples on Amersham MegaBACE parallel. Furthermore, sequencing is carried out by observ- could be achieved in one run. This generation of sequencers ing and recording optical events through microscopic played a pivotal role in DNA sequence production at later apparatus during iterative sequencing cycles - a serial ex- stage of the Human Genome Project and helped to accele- tension of primed template by either DNA polymerase [8] rate the project completion. They have been continuously or ligase [9]. used until this day due to key advantages in its raw data Several key characteristics can be easily observed based accuracy and sequence read length. on the general description. First, massive parallelism can be Through decades of gradual improvement, 1st-generation achieved through ordered or disordered array configuration sequencer can be applied to achieve sequencing length up to that offers high degree of information density. Theoretically, 1000 bp, with raw accuracy as high as 99.999%, at a cost as this is only limited by the diffraction limit of light (i.e., half little as $0.50/kilobase and throughput close to 600000 of the wavelength used for detection of
Recommended publications
  • Wo 2007/086935 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date PCT (10) International Publication Number 2 August 2007 (02.08.2007) WO 2007/086935 A2 (51) International Patent Classification: Not classified (US). MYERS, Eugene, W. [-/US]; 20 Commercial Street, Branford, CT 06405 (US). SIMPSON, John, (21) International Application Number: W. [US/US]; 23 Woodland Road, Suite B4, Madison, PCT/US2006/030235 CT 06443 (US). VOLKMER, Greg, A. [-/US]; 20 Commercial Street, Branford, CT 06405 (US). (22) International Filing Date: 1 August 2006 (01.08.2006) (74) Agent: HOPKINS, Brian, P.; Mintz, Levin, Cohn, Ferris, (25) Filing Language: English Glovsky And Popeo, Rc, Chrysler Center, 666 Third Av enue, New York, NY 10017 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of national protection available): AE, AG, AL, AM, 11/195,254 1 August 2005 (01.08.2005) US AT,AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, (71) Applicant (for all designated States except US): 454 LIFE GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, SCIENCES CORPORATION [US/US]; 20 Commercial KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, Street, Branford, CT 06405 (US). LU, LV,LY,MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, (72) Inventors; and SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, (75) Inventors/Applicants (for US only): MCDADE, Keith, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW E.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,557,518 B2 Jovanovich Et Al
    US008557518B2 (12) United States Patent (10) Patent No.: US 8,557,518 B2 Jovanovich et al. (45) Date of Patent: Oct. 15, 2013 (54) MCROFLUDIC AND NANOFLUIDC (56) References Cited DEVICES, SYSTEMS, AND APPLICATIONS U.S. PATENT DOCUMENTS (75) Inventors: Stevan Bogdan Jovanovich, Livermore, 3,190,310 A 6/1965 Honsinger CA (US); Iuliu I. Blaga, Fremont, CA 11/1967 Ando et al. (US); Michael Nguyen, San Jose, CA 3,352,643 A (US); William D. Nielsen, San Jose, CA (Continued) (US); Mattias Vangbo, Fremont, CA (US) FOREIGN PATENT DOCUMENTS CA 2433145 A1 5, 2002 (73) Assignee: IntegenX Inc., Pleasanton, CA (US) EP O459.241 B1 12, 1991 (*) Notice: Subject to any disclaimer, the term of this (Continued) patent is extended or adjusted under 35 OTHER PUBLICATIONS U.S.C. 154(b) by 109 days. Shaikh et all “A modular microfluidic archetecture for integrated (21) Appl. No.: 12/845,650 biochemical analysis”, PNAS, 2005, 102: 9745-9750.* (22) Filed: Jul. 28, 2010 (Continued) (65) Prior Publication Data Primary Examiner — Betty Forman US 2012/O1151.89 A1 May 10, 2012 (57) ABSTRACT Related U.S. Application Data The present invention discloses the integration of program (63) Continuation of application No. 12/526,015, filed as mable microfluidic circuits to achieve practical applications application No. PCT/US2008/053099 on Feb. 5, 2008. to process biochemical and chemical reactions and to inte grate these reactions. In some embodiments workflows for (60) Provisional application No. 60/899,630, filed on Feb. biochemical reactions or chemical workflows are combined. 5, 2007. Microvalves such as programmable microfluidic circuit with Y valves and flow through valves are disclosed.
    [Show full text]
  • Genetic Sequence Analysis by Microarray Technology EMILIE HULTIN
    Genetic Sequence Analysis by Microarray Technology EMILIE HULTIN Royal Institute of Technology School of Biotechnology Stockholm 2007 © Emilie Hultin Royal Institute of Technology AlbaNova University Center School of Biotechnology SE-106 91 Stockholm Sweden Printed at Universitetsservice US-AB Box 700 14 SE-100 44 Stockholm Sweden ISBN 978-91-7178-609-8 Emilie Hultin (2007): Genetic Sequence Analysis by Microarray Technology School of Biotechnology, Royal Institute of Technology (KTH), Stockholm, Sweden ISBN 978-91-7178-609-8 Abstract Developments within the field of genetic analysis have during the last decade become enormous. Advances in DNA sequencing technology have increased throughput from a thousand bases to over a billion bases in a day and decreased the cost thousandfold per base. Nevertheless, to sequence complex genomes like the human is still very expensive and efforts to attain even higher throughputs for less money are undertaken by researchers and companies. Genotyping systems for single nucleotide polymorphism (SNP) analysis with whole genome coverage have also been developed, with low cost per SNP. There is, however, a need for genotyping assays that are more cost efficient per sample with considerably higher accuracy. This thesis is focusing on a technology, based on competitive allele- specific extension and microarray detection, for genetic analysis. To increase specificity in allele-specific extension (ASE), a nucleotide degrading enzyme, apyrase, was introduced to compete with the polymerase, only allowing the fast, perfect matched primer extension to occur. The aim was to develop a method for analysis of around twenty loci in hundreds of samples in a high-throughput microarray format.
    [Show full text]
  • Resolution of DNA Mixtures and Analysis of Degraded DNA Using the 454 DNA Sequencing Technology
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Resolution of DNA Mixtures and Analysis of Degraded DNA Using the 454 DNA Sequencing Technology Author(s): Cassandra D. Calloway, Ph.D., Hanna Kim, Henry Erlich Document No.: 249100 Date Received: August 2015 Award Number: 2010-DN-BX-K141 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this federally funded grant report available electronically. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Resolution of DNA Mixtures and Analysis of Degraded DNA Using the 454 DNA Sequencing Technology Grant #:2010-DN-BX-K141 Principal Investigator Cassandra D. Calloway, PhD Authors Cassandra D. Calloway, PhD, Hanna Kim, and Henry Erlich This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. I. Abstract The massively parallel and clonal nature of next generation sequencing (NGS) technologies has the potential to revolutionize the forensics DNA field. NGS is capable of analyzing sequence polymorphisms (e.g. mtDNA, SNPs) as well as length polymorphisms (e.g. STRs) on the same platform. Moreover, sequencing STR markers will detect any sequence polymorphisms in the STR loci, thus increasing the discrimination potential of these widely used markers.
    [Show full text]
  • Bio 215 Course Title: General Biochemistry Laboratory I
    NATIONAL OPEN UNIVERSITY OF NIGERIA SCHOOL OF SCIENCE AND TECHNOLOGY COURSE CODE: BIO 215 COURSE TITLE: GENERAL BIOCHEMISTRY LABORATORY I 1 BIO 215: GENERAL BIOCHEMISTRY LABORATORY I Course Developer: DR (MRS.) AKIN-OSANAIYE BUKOLA CATHERINE UNIVERISTY OF ABUJA Course Editor: Dr Ahmadu Anthony Programme Leader: Professor A. Adebanjo Course Coordinator: Adams Abiodun E. 2 UNIT 1 INTRODUCTION TO LABORATORY AND LABORATORY EQUIPMENT CONTENTS 1.0 Introduction 2.0 Objectives 3.0 Main Body 3.1 What is a Laboratory? 3.2 Laboratory Equipment 4.0 Conclusion 5.0 Summary 6.0 Tutor-marked Assignments 7.0 References/Further Readings 1.0 INTRODUCTION Scientific research and investigations will be of little value without good field and laboratory work. These investigations are normally carried out through the active use of processes which involves laboratory or other hands-on activities. Many devices and products used in everyday life resulted from laboratory works. They include car engines, plastics, radios, televisions, synthetic fabrics, etc. 3 2.0 OBJECTIVES Upon completion of studying this unit, you should be able to: 1. Define the meaning of laboratory 2. List different types of laboratories 3. Identify different types of laboratory equipment 3.0 MAIN BODY 3.1 What is a Laboratory? A laboratory informally, lab is a facility that provides controlled conditions in which scientific research, experiments, and measurement may be performed. It is a place equipped for investigative procedures and for the preparation of reagents, therapeutic chemical materials, and so on. The title of laboratory is also used for certain other facilities where the processes or equipment used are similar to those in scientific laboratories.
    [Show full text]
  • 1455189355674.Pdf
    THE STORYTeller’S THESAURUS FANTASY, HISTORY, AND HORROR JAMES M. WARD AND ANNE K. BROWN Cover by: Peter Bradley LEGAL PAGE: Every effort has been made not to make use of proprietary or copyrighted materi- al. Any mention of actual commercial products in this book does not constitute an endorsement. www.trolllord.com www.chenaultandgraypublishing.com Email:[email protected] Printed in U.S.A © 2013 Chenault & Gray Publishing, LLC. All Rights Reserved. Storyteller’s Thesaurus Trademark of Cheanult & Gray Publishing. All Rights Reserved. Chenault & Gray Publishing, Troll Lord Games logos are Trademark of Chenault & Gray Publishing. All Rights Reserved. TABLE OF CONTENTS THE STORYTeller’S THESAURUS 1 FANTASY, HISTORY, AND HORROR 1 JAMES M. WARD AND ANNE K. BROWN 1 INTRODUCTION 8 WHAT MAKES THIS BOOK DIFFERENT 8 THE STORYTeller’s RESPONSIBILITY: RESEARCH 9 WHAT THIS BOOK DOES NOT CONTAIN 9 A WHISPER OF ENCOURAGEMENT 10 CHAPTER 1: CHARACTER BUILDING 11 GENDER 11 AGE 11 PHYSICAL AttRIBUTES 11 SIZE AND BODY TYPE 11 FACIAL FEATURES 12 HAIR 13 SPECIES 13 PERSONALITY 14 PHOBIAS 15 OCCUPATIONS 17 ADVENTURERS 17 CIVILIANS 18 ORGANIZATIONS 21 CHAPTER 2: CLOTHING 22 STYLES OF DRESS 22 CLOTHING PIECES 22 CLOTHING CONSTRUCTION 24 CHAPTER 3: ARCHITECTURE AND PROPERTY 25 ARCHITECTURAL STYLES AND ELEMENTS 25 BUILDING MATERIALS 26 PROPERTY TYPES 26 SPECIALTY ANATOMY 29 CHAPTER 4: FURNISHINGS 30 CHAPTER 5: EQUIPMENT AND TOOLS 31 ADVENTurer’S GEAR 31 GENERAL EQUIPMENT AND TOOLS 31 2 THE STORYTeller’s Thesaurus KITCHEN EQUIPMENT 35 LINENS 36 MUSICAL INSTRUMENTS
    [Show full text]
  • Next-Generation DNA Sequencing Techniques Review
    New Biotechnology Volume 25, Number 4 April 2009 REVIEW Next-generation DNA sequencing techniques Review Wilhelm J. Ansorge Ecole Polytechnique Federal Lausanne, EPFL, Switzerland Next-generation high-throughput DNA sequencing techniques are opening fascinating opportunities in the life sciences. Novel fields and applications in biology and medicine are becoming a reality, beyond the genomic sequencing which was original development goal and application. Serving as examples are: personal genomics with detailed analysis of individual genome stretches; precise analysis of RNA transcripts for gene expression, surpassing and replacing in several respects analysis by various microarray platforms, for instance in reliable and precise quantification of transcripts and as a tool for identification and analysis of DNA regions interacting with regulatory proteins in functional regulation of gene expression. The next-generation sequencing technologies offer novel and rapid ways for genome-wide characterisation and profiling of mRNAs, small RNAs, transcription factor regions, structure of chromatin and DNA methylation patterns, microbiology and metagenomics. In this article, development of commercial sequencing devices is reviewed and some European contributions to the field are mentioned. Presently commercially available very high-throughput DNA sequencing platforms, as well as techniques under development, are described and their applications in bio-medical fields discussed. Introduction Sanger method was used in the first automated fluorescent project Next-generation high-throughput DNA sequencing techniques, for sequencing of a genome region, in which sequence determina- which are opening fascinating new opportunities in biomedicine, tion of the complete gene locus for the HPRT gene was performed were selected by Nature Methods as the method of the year in 2007 using the EMBL technique; in that project the important concept of [1].
    [Show full text]
  • Laboratory Glassware
    This week we are launching Wikivoyage . Join us in creating a free travel guide that anyone can edit. Laboratory glassware From Wikipedia, the free encyclopedia Jump to: navigation, search This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (February 2011) Three beakers, an Erlenmeyer flask, a graduated cylinder and a volumetric flask Brown glass jars with some clear lab glassware in the background Laboratory glassware refers to a variety of equipment, traditionally made of glass, used for scientific experiments and other work in science, especially in chemistry and biology laboratories. Some of the equipment is now made of plastic for cost, ruggedness, and convenience reasons, but glass is still used for some applications because it is relatively inert, transparent, more heat-resistant than some plastics up to a point, and relatively easy to customize. Borosilicate glasses are often used because they are less subject to thermal stress and are common for reagent bottles. For some applications quartz glass is used for its ability to withstand high temperatures or its transparency in certain parts of the electromagnetic spectrum. In other applications, especially some storage bottles, darkened brown or amber (actinic) glass is used to keep out much of the UV and IR radiation so that the effect of light on the contents is minimized. Special-purpose materials are also used; for example, hydrofluoric acid is stored and used in polyethylene containers because it reacts with glass.[1] For pressurized reaction, heavy-wall glass is used for pressure reactor.
    [Show full text]
  • Synthesis of Sequence-Verified Nucleic Acids Synthese Von Nukleinsäuren Mit Verifizierter Sequenz Synthèse D’Acides Nucléiques À Séquence Vérifiée
    (19) TZZ ¥__T (11) EP 2 398 915 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12Q 1/68 (2006.01) C12N 15/10 (2006.01) 24.08.2016 Bulletin 2016/34 (86) International application number: (21) Application number: 10705856.2 PCT/EP2010/052140 (22) Date of filing: 19.02.2010 (87) International publication number: WO 2010/094772 (26.08.2010 Gazette 2010/34) (54) SYNTHESIS OF SEQUENCE-VERIFIED NUCLEIC ACIDS SYNTHESE VON NUKLEINSÄUREN MIT VERIFIZIERTER SEQUENZ SYNTHÈSE D’ACIDES NUCLÉIQUES À SÉQUENCE VÉRIFIÉE (84) Designated Contracting States: (56) References cited: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR WO-A2-2008/022789 HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR • CALVET J P: "MOLECULAR APPROACHES FOR ANALYZING DIFFERENTIAL GENE (30) Priority: 20.02.2009 US 154091 P EXPRESSION: DIFFERENTIAL CDNA LIBRARY CONSTRUCTION AND SCREENING" PEDIATRIC (43) Date of publication of application: NEPHROLOGY, SPRINGER VERLAG, BERLIN, 28.12.2011 Bulletin 2011/52 DE LNKD- DOI:10.1007/BF00857891, vol. 5, no. 6, 1 January 1991 (1991-01-01) , pages 751-757, (73) Proprietor: Synthetic Genomics, Inc. XP008018106 ISSN: 0931-041X La Jolla, CA 92037 (US) • DROEGE M ET AL: "The Genome Sequencer FLX(TM) System-Longer reads, more (72) Inventors: applications, straight forward bioinformatics and • STÄHLER, Peer F. more complete data sets" JOURNAL OF 68167 Mannheim (DE) BIOTECHNOLOGY, ELSEVIER SCIENCE • CARAPITO, Raphaël PUBLISHERS, AMSTERDAM, NL LNKD- F-67100 Strasbourg (FR) DOI:10.1016/J.JBIOTEC.2008.03.021, vol.
    [Show full text]
  • Effects of Nitrogen-Fixing Symbiotic Cyanobacteria on the Microbial Ecology of the Coral, Montastraea Cavernosa
    University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Spring 2012 Effects of nitrogen-fixing symbiotic cyanobacteria on the microbial ecology of the coral, Montastraea cavernosa Jessica K. Jarett University of New Hampshire, Durham Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation Jarett, Jessica K., "Effects of nitrogen-fixing symbiotic cyanobacteria on the microbial ecology of the coral, Montastraea cavernosa" (2012). Doctoral Dissertations. 652. https://scholars.unh.edu/dissertation/652 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. EFFECTS OF NITROGEN-FIXING SYMBIOTIC CYANOBACTERIA ON THE MICROBIAL ECOLOGY OF THE CORAL, MONTASTRAEA CAVERNOSA BY JESSICA KJARETT BS, Southampton College, 2005 DISSERTATION Submitted to the University of New Hampshire in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Microbiology May, 2012 UMI Number: 3525060 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. OiSi«Wior» Ftattlisttlfl UMI 3525060 Published by ProQuest LLC 2012. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved.
    [Show full text]
  • Dna Mutation/Methylation Screening Method for Colon Cancer Screening
    DNA MUTATION/METHYLATION SCREENING METHOD FOR COLON CANCER SCREENING WEI MENG Bachelor of Science in Chemical Engineering Zhengzhou University July, 2003 Submitted in partial fulfillment of requirements for the degree DOCTOR OF PHILOSOPHY IN CLINICAL/BIOANALYTICAL CHEMISTRY at CLEVELAND STATE UNIVERSITY November, 2010 This dissertation has been approved for the Department of Chemistry and for the College of Graduate Studies of Cleveland State University By __________________________________________________ Date______________ Dr. Baochuan Guo, Dept of Chemistry/Cleveland State University Major Advisor __________________________________________________ Date______________ Dr. Aimin Zhou, Dept of Chemistry/Cleveland State University Advisory committee Member __________________________________________________ Date______________ Dr. Anton Komar, Dept of BGES/Cleveland State University Advisory committee Member __________________________________________________ Date______________ Dr. John Masnovi, Dept of Chemistry/Cleveland State University Advisory committee Member __________________________________________________ Date______________ Dr. Stan Duraj, Dept of Chemistry/Cleveland State University Advisory committee Member ACKNOWLEDGMENTS First of all, I would like to thank my advisor, Dr. Baochuan Guo, Ph.D, Professor of Chemistry, Cleveland State University for his guidance. During five years of study, he encouraged me and led me into a new research field which I haven’t touched before. My scientific training was benefited from his unforgettable support and kind management. Members of Dr.Guo’s research group are quite friendly and supportive. I used to be an engineering majored student and was lack of biochemistry knowledge. The group members spend plenty of time to train me when I stepped into the lab. The lab members, including Xiyuan Sun, Xiangzhu Xiao, Yiding Liu, Xiaopeng Li and Xiaohan Cai, provided me their important experience and discussion on my several projects.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,323,305 B2 Leamon Et Al
    USOO73233 05B2 (12) United States Patent (10) Patent No.: US 7,323,305 B2 LeamOn et al. (45) Date of Patent: Jan. 29, 2008 (54) METHODS OF AMPLFYING AND (52) U.S. Cl. ............................. 435/6; 435/8; 435/91.2: SEQUENCING NUCLEIC ACIDS 435/91.52; 435/175; 435/287.2:435/288.7; 536/24.2:536/24.33 (75) Inventors: John H. Leamon, Guilford, CT (US); (58) Field of Classification Search ..................... None Kenton L. Lohman, Guilford, CT See application file for complete search history. (US); Jonathan M. Rothberg, Guilford, CT (US); Michael P. Weiner, (56) References Cited Guilford, CT (US) U.S. PATENT DOCUMENTS (73) Assignee: 454 Life Sciences Corporation, 4,683, 195 A 7, 1987 Mullis et al. Branford, CT (US) (*) Notice: Subject to any disclaimer, the term of this (Continued) patent is extended or adjusted under 35 FOREIGN PATENT DOCUMENTS U.S.C. 154(b) by 289 days. EP O 373 203 8, 1994 (21) Appl. No.: 10/767,779 (22) Filed: Sep. 22, 2004 (Continued) (65) Prior Publication Data OTHER PUBLICATIONS US 2005/O 130173 A1 Jun. 16, 2005 Nakano et al. Single-molecule PCR using water-in-oil emulsion. J Biotechnol. Apr. 24, 2003; 102(2): 117-24.* Related U.S. Application Data (60) Provisional application No. 60/497,985, filed on Aug. (Continued) 25, 2003, provisional application No. 60/476,313, Primary Examiner Young J. Kim filed on Jun. 6, 2003, provisional application No. Assistant Examiner Samuel Woolwine 60/476,504, filed on Jun. 6, 2003, provisional appli (74) Attorney, Agent, or Firm—Ivor R.
    [Show full text]